GlassScriptPhysician profile
Kelley Erin Stoddard
NPI 1932186202
$933.80
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $176 · 2021: $102 · 2022: $218 · 2023: $136 · 2024: $33.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $190.76 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $138.17 | 2019-2023 | |
| Abbvie INC. | $130.82 | 2019-2023 | Liletta |
| Minerva Surgical, INC | $83.34 | 2019 | |
| Scynexis, INC. | $48.29 | 2022 | |
| Pfizer INC. | $45.30 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $35.41 | 2023-2024 | |
| Exact Sciences Corporation | $33.91 | 2023 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $33.38 | 2021 | |
| Daiichi Sankyo INC. | $28.31 | 2019-2020 | |
| Smith+Nephew, INC. | $23.22 | 2024 | Pico |
| Myovant Sciences INC. | $22.69 | 2022 | |
| Astellas Pharma US INC | $21.99 | 2020 | |
| Duchesnay USA Incorporated | $18.89 | 2019 | |
| Allergan, INC. | $16.09 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $14.48 | 2021 | |
| Coopersurgical, INC. | $13.61 | 2022 | |
| Avion Pharmaceuticals | $12.62 | 2020 | |
| Lupin INC. | $11.66 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelley Stoddard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.